Abstract
In January 2020, the FDA approved oral immunotherapy (OIT) for the treatment of peanut allergy in children ages 4 to 17. In June 2020, our clinic began offering FDA-approved peanut OIT with Palforzia. We report the real-world application of FDA-approved peanut OIT at a tertiary care pediatric center.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
